• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Control of Platelet CLEC-2-Mediated Activation by Receptor Clustering and Tyrosine Kinase Signaling.通过受体聚集和酪氨酸激酶信号传导控制血小板CLEC-2介导的激活
Biophys J. 2020 Jun 2;118(11):2641-2655. doi: 10.1016/j.bpj.2020.04.023. Epub 2020 Apr 29.
2
C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice.C 型凝集素样受体 2(CLEC-2)是小鼠κ-卡拉胶诱导尾血栓形成模型的关键调节因子。
Platelets. 2023 Dec;34(1):2281941. doi: 10.1080/09537104.2023.2281941. Epub 2023 Nov 27.
3
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.C型凝集素受体CLEC-2通过一种新的依赖于脾酪氨酸激酶(Syk)的机制激活血小板。
Blood. 2006 Jan 15;107(2):542-9. doi: 10.1182/blood-2005-05-1994. Epub 2005 Sep 20.
4
CLEC-2 activates Syk through dimerization.CLEC-2 通过二聚化激活 Syk。
Blood. 2010 Apr 8;115(14):2947-55. doi: 10.1182/blood-2009-08-237834. Epub 2010 Feb 12.
5
Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.不同的信号通路调节血小板中免疫酪氨酸激活基序(ITAM)和半ITAM受体下游的Syk蛋白激活。
J Biol Chem. 2015 May 1;290(18):11557-68. doi: 10.1074/jbc.M114.629527. Epub 2015 Mar 12.
6
A Comprehensive Tyrosine Phosphoproteomic Analysis Reveals Novel Components of the Platelet CLEC-2 Signaling Cascade.一项全面的酪氨酸磷酸化蛋白质组学分析揭示了血小板 CLEC-2 信号级联的新成分。
Thromb Haemost. 2020 Feb;120(2):262-276. doi: 10.1055/s-0039-3400295. Epub 2020 Jan 4.
7
Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells.Syk和Src家族激酶调节C型凝集素受体2(CLEC-2)介导的血小板内皮细胞黏附分子(Podoplanin)聚集以及血小板与淋巴管内皮细胞的黏附。
J Biol Chem. 2014 Dec 26;289(52):35695-710. doi: 10.1074/jbc.M114.584284. Epub 2014 Nov 3.
8
The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.新型Syk抑制剂R406揭示了血小板中糖蛋白VI(GPVI)和C型凝集素样受体2(CLEC-2)信号起始的机制差异。
J Thromb Haemost. 2009 Jul;7(7):1192-9. doi: 10.1111/j.1538-7836.2009.03451.x. Epub 2009 Apr 24.
9
G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.G6b-B抑制糖蛋白VI和C型凝集素样受体2(CLEC-2)介导的组成性信号传导和激动剂诱导的信号传导。
J Biol Chem. 2008 Dec 19;283(51):35419-27. doi: 10.1074/jbc.M806895200. Epub 2008 Oct 27.
10
Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3α/β.Akt和丝裂原活化蛋白激酶通过抑制糖原合酶激酶3α/β增强C型凝集素样受体2介导的血小板活化。
J Thromb Haemost. 2015 Jun;13(6):1139-50. doi: 10.1111/jth.12954. Epub 2015 May 9.

引用本文的文献

1
Humanized murine models of platelet function.血小板功能的人源化小鼠模型。
Curr Opin Hematol. 2025 Jul 14. doi: 10.1097/MOH.0000000000000879.
2
The Ways of the Virus: Interactions of Platelets and Red Blood Cells with SARS-CoV-2, and Their Potential Pathophysiological Significance in COVID-19.病毒的传播途径:血小板和红细胞与 SARS-CoV-2 的相互作用,及其在 COVID-19 中的潜在病理生理学意义。
Int J Mol Sci. 2023 Dec 9;24(24):17291. doi: 10.3390/ijms242417291.
3
Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon.儿科患者伴血小板功能异常的kaposiform 血管内皮细胞瘤/卡波西样血管内皮瘤现象。
Blood Adv. 2023 Sep 12;7(17):4936-4949. doi: 10.1182/bloodadvances.2022009590.
4
Experimental validation of computerised models of clustering of platelet glycoprotein receptors that signal via tandem SH2 domain proteins.血小板糖蛋白受体通过串联 SH2 结构域蛋白信号的聚类的计算机模型的实验验证。
PLoS Comput Biol. 2022 Nov 28;18(11):e1010708. doi: 10.1371/journal.pcbi.1010708. eCollection 2022 Nov.
5
Ex vivo observation of granulocyte activity during thrombus formation.体外观察血栓形成过程中粒细胞的活性。
BMC Biol. 2022 Feb 7;20(1):32. doi: 10.1186/s12915-022-01238-x.
6
Longitudinal multiparametric characterization of platelet dysfunction in COVID-19: Effects of disease severity, anticoagulation therapy and inflammatory status.新型冠状病毒肺炎患者血小板功能障碍的纵向多参数特征:疾病严重程度、抗凝治疗和炎症状态的影响。
Thromb Res. 2022 Mar;211:27-37. doi: 10.1016/j.thromres.2022.01.013. Epub 2022 Jan 15.
7
ASGR1 and Its Enigmatic Relative, CLEC10A.ASGR1 及其神秘的同源物 CLEC10A。
Int J Mol Sci. 2020 Jul 8;21(14):4818. doi: 10.3390/ijms21144818.
8
Development of a Simple Kinetic Mathematical Model of Aggregation of Particles or Clustering of Receptors.粒子聚集或受体聚类的简单动力学数学模型的开发。
Life (Basel). 2020 Jun 26;10(6):97. doi: 10.3390/life10060097.

本文引用的文献

1
Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation.种间蛋白质表达差异不影响糖蛋白VI介导的激活的时空调节。
J Thromb Haemost. 2020 Feb;18(2):485-496. doi: 10.1111/jth.14673. Epub 2019 Dec 6.
2
Quantitative dynamics of reversible platelet aggregation: mathematical modelling and experiments.血小板可逆聚集的定量动力学:数学建模与实验。
Sci Rep. 2019 Apr 17;9(1):6217. doi: 10.1038/s41598-019-42701-0.
3
Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα.合成糖聚合物和天然褐藻胶通过 PEAR1 和 GPIbα 引起人血小板聚集。
Blood Adv. 2019 Feb 12;3(3):275-287. doi: 10.1182/bloodadvances.2018024950.
4
Platelet biology and functions: new concepts and clinical perspectives.血小板生物学和功能:新概念和临床视角。
Nat Rev Cardiol. 2019 Mar;16(3):166-179. doi: 10.1038/s41569-018-0110-0.
5
Mathematical Techniques for Understanding Platelet Regulation and the Development of New Pharmacological Approaches.理解血小板调节及开发新药理学方法的数学技术
Methods Mol Biol. 2018;1812:255-279. doi: 10.1007/978-1-4939-8585-2_15.
6
An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia.血小板在慢性髓性白血病血管生成、细胞凋亡和自噬中的作用概述
Cancer Cell Int. 2017 Oct 30;17:89. doi: 10.1186/s12935-017-0460-4. eCollection 2017.
7
G pathway regulates proximal C-type lectin-like receptor-2 (CLEC-2) signaling in platelets.G通路调节血小板中的近端C型凝集素样受体2(CLEC-2)信号传导。
J Biol Chem. 2017 Sep 1;292(35):14516-14531. doi: 10.1074/jbc.M117.791012. Epub 2017 Jul 13.
8
Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.CLEC-2 缺乏的小鼠对深静脉血栓形成具有抵抗力。
Blood. 2017 Apr 6;129(14):2013-2020. doi: 10.1182/blood-2016-09-742999. Epub 2017 Jan 19.
9
Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets.糖蛋白VI(GPVI)二聚体在黏附于胶原蛋白时发生聚集,作为调节血小板中GPVI信号传导的一种机制。
J Thromb Haemost. 2017 Mar;15(3):549-564. doi: 10.1111/jth.13613. Epub 2017 Feb 16.
10
C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice.C 型凝集素样受体 2 促进荷瘤小鼠血源性肿瘤转移和促血栓形成状态。
J Thromb Haemost. 2017 Mar;15(3):513-525. doi: 10.1111/jth.13604. Epub 2017 Feb 14.

通过受体聚集和酪氨酸激酶信号传导控制血小板CLEC-2介导的激活

Control of Platelet CLEC-2-Mediated Activation by Receptor Clustering and Tyrosine Kinase Signaling.

作者信息

Martyanov Alexey A, Balabin Fedor A, Dunster Joanne L, Panteleev Mikhail A, Gibbins Jonathan M, Sveshnikova Anastasia N

机构信息

Center for Theoretical Problems of Physico-chemical Pharmacology, Russian Academy of Sciences, Moscow, Russia; Dmitry Rogachev National Medical Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia; Institute for Biochemical Physics, Russian Academy of Sciences, Moscow, Russia; Faculty of Physics, Lomonosov Moscow State University, Moscow, Russia.

Center for Theoretical Problems of Physico-chemical Pharmacology, Russian Academy of Sciences, Moscow, Russia; Dmitry Rogachev National Medical Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.

出版信息

Biophys J. 2020 Jun 2;118(11):2641-2655. doi: 10.1016/j.bpj.2020.04.023. Epub 2020 Apr 29.

DOI:10.1016/j.bpj.2020.04.023
PMID:32396849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7264845/
Abstract

Platelets are blood cells responsible for vascular integrity preservation. The activation of platelet receptor C-type lectin-like receptor II-type (CLEC-2) could partially mediate the latter function. Although this receptor is considered to be of importance for hemostasis, the rate-limiting steps of CLEC-2-induced platelet activation are not clear. Here, we aimed to investigate CLEC-2-induced platelet signal transduction using computational modeling in combination with experimental approaches. We developed a stochastic multicompartmental computational model of CLEC-2 signaling. The model described platelet activation beginning with CLEC-2 receptor clustering, followed by Syk and Src family kinase phosphorylation, determined by the cluster size. Active Syk mediated linker adaptor for T cell protein phosphorylation and membrane signalosome formation, which resulted in the activation of Bruton's tyrosine kinase, phospholipase and phosphoinositide-3-kinase, calcium, and phosphoinositide signaling. The model parameters were assessed from published experimental data. Flow cytometry, total internal reflection fluorescence and confocal microscopy, and western blotting quantification of the protein phosphorylation were used for the assessment of the experimental dynamics of CLEC-2-induced platelet activation. Analysis of the model revealed that the CLEC-2 receptor clustering leading to the membrane-based signalosome formation is a critical element required for the accurate description of the experimental data. Both receptor clustering and signalosome formation are among the rate-limiting steps of CLEC-2-mediated platelet activation. In agreement with these predictions, the CLEC-2-induced platelet activation, but not activation mediated by G-protein-coupled receptors, was strongly dependent on temperature conditions and cholesterol depletion. Besides, the model predicted that CLEC-2-induced platelet activation results in cytosolic calcium spiking, which was confirmed by single-platelet total internal reflection fluorescence microscopy imaging. Our results suggest a refined picture of the platelet signal transduction network associated with CLEC-2. We show that tyrosine kinase activation is not the only rate-limiting step in CLEC-2-induced activation of platelets. Translocation of receptor-agonist complexes to the signaling region and linker adaptor for T cell signalosome formation in this region are limiting CLEC-2-induced activation as well.

摘要

血小板是负责维持血管完整性的血细胞。血小板受体C型凝集素样受体II型(CLEC-2)的激活可部分介导后一种功能。尽管该受体被认为对止血很重要,但CLEC-2诱导的血小板激活的限速步骤尚不清楚。在这里,我们旨在结合计算建模和实验方法来研究CLEC-2诱导的血小板信号转导。我们开发了一个CLEC-2信号传导的随机多隔室计算模型。该模型描述了从CLEC-2受体聚集开始的血小板激活过程,随后是Syk和Src家族激酶的磷酸化,其由聚集大小决定。活性Syk介导T细胞蛋白磷酸化的接头衔接子和膜信号小体的形成,这导致布鲁顿酪氨酸激酶、磷脂酶和磷酸肌醇-3-激酶、钙和磷酸肌醇信号的激活。模型参数根据已发表的实验数据进行评估。流式细胞术、全内反射荧光和共聚焦显微镜以及蛋白质磷酸化的蛋白质印迹定量用于评估CLEC-2诱导的血小板激活的实验动力学。对模型的分析表明,导致基于膜的信号小体形成的CLEC-2受体聚集是准确描述实验数据所需的关键要素。受体聚集和信号小体形成都是CLEC-2介导的血小板激活的限速步骤。与这些预测一致,CLEC-2诱导的血小板激活,而不是由G蛋白偶联受体介导的激活,强烈依赖于温度条件和胆固醇耗竭。此外,该模型预测CLEC-2诱导的血小板激活会导致胞质钙尖峰,这通过单血小板全内反射荧光显微镜成像得到证实。我们的结果提示了与CLEC-2相关的血小板信号转导网络的精细图景。我们表明酪氨酸激酶激活不是CLEC-2诱导的血小板激活中的唯一限速步骤。受体激动剂复合物向信号区域的转位以及该区域中T细胞信号小体形成的接头衔接子也限制了CLEC-2诱导的激活。